<DOC>
	<DOCNO>NCT01147419</DOCNO>
	<brief_summary>Different strategy exist treatment chronic long occlusion superficial femoral artery . Traditionally , patient treat bypass . If great saphenous vein unavailable , doctor choose artificial vessel graft . Now , skill endovascular treatment develop rapidly , lot doctor think patient could treat stent . The purpose trial compare stent artificial blood vessel bypass treatment long occlusion superficial femoral artery . The study hypothesis patency rate comparable therefore minimal invasive treatment stent consider patient .</brief_summary>
	<brief_title>Comparison Stent Prothesis Bypass Superficial Femoral Artery</brief_title>
	<detailed_description>This multi-center , prospective , randomize , control trial compare therapeutic effect stent artificial blood vessel bypass chronic long occlusion superficial femoral artery . Totally 200 patient enter trial . The study population consist patient long superficial femoral stenosis occlusion lesion ( ≥15 cm ) , present symptomatic ischemia（Rutherford 3-6） . The lesion extend beyond aortoiliac artery blow-knee popliteal artery , least 1 vessel infra-popliteal runoff foot . Trial participant randomize either stent group artificial blood vessel bypass group . Patients follow 3 year . Study examinations do screening , procedure time , 1 , 6 , 12 , 24 36 month procedure . This study conduct 3 center Beijing , China .</detailed_description>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
	<mesh_term>Blood Substitutes</mesh_term>
	<criteria>The patient volunteer join trial sign formal consent . The patient ≥45 yearold ≤80 yearold . The patient suffer symptomatic leg ischemia rutherford classification3 , 4 , 5 6 . The presentation severe intermittent claudication , rest pain , ulcer gangrene . The total length femoral popliteal artery lesion ( include ≥75 % stenosis occlusion ) least 15cm . The femoralpopliteal artery never receive bypass endovascular therapy . No obvious stenosis occlusion aortoiliac artery ; lesion could treat simultaneously already cure . No obvious stenosis belowknee popliteal artery ; least 1 vessel infrapopliteal runoff foot . No surgical contraindication ; infection operation region . No available saphenous vein . Refuse random treatment . Previous operation superficial femoral artery . Acute low extremity arterial thrombosis . Serious major organ failure . Allergic contrast agent contrast nephropathy . No clinical compliance unfit join trial .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>critical limb ischemia</keyword>
	<keyword>peripheral artery occlusive disease</keyword>
	<keyword>femoropopliteal artery bypass</keyword>
	<keyword>Stent</keyword>
</DOC>